Shares in clinical trials firm Icon yet to recover after internal investigation into accounting practices

Shares in Irish clinical trials firm Icon remain 28pc lower than where they were trading just a week before the group warned in February that it was engaged in an “ongoing internal investigation” into certain accounting practices and controls.